Sarcoma drug combo trial halted early – safety data collected
Disease control
Terminated
This early-phase trial tested a new drug (AZD1390) with or without another drug (durvalumab) plus radiation in 12 adults with soft tissue sarcoma before surgery. The goal was to check safety, side effects, and wound healing. The study was stopped early, but the information gather…
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 17, 2026 05:49 UTC